Stocks That Hit 52-Week Lows On Monday On Monday, 100 companies reached new 52-week lows. Benzinga · Jul 25, 2022
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall… Benzinga · Jun 28, 2022
eFFECTOR Therapeutics's Return On Capital Employed Overview According to Benzinga Pro, during Q4, eFFECTOR Therapeutics (NASDAQ:EFTR) earned $19.05 million, a 114.54% increase from the preceding quarter. eFFECTOR Therapeutics's sales decreased to $311.00 thousand, a 27.17% change since Q3. Benzinga · Mar 17, 2022